Trending News

Novo Nordisk has expanded the reach of its oral Wegovy weight-loss drug, debuting the treatment in the UAE as its first international commercial market.

Eli Lilly’s leadership has hinted at an aggressive M&A strategy that looks beyond the firm's traditional therapeutic focus, marking a potential shift in how the company deploys capital.

Novo Nordisk has debuted its oral Wegovy pill in the UAE, marking the first international rollout of the drug outside the US. The move signals a major test for the firm's global obesity treatment strategy.